Authors/Disclosures
|
Edward J. Kasarskis, MD, PhD, FAAN
(UK Healthcare)
|
The institution of Dr. Kasarskis has received research support from Healey Platform Trial Group. The institution of Dr. Kasarskis has received research support from Amylyx . The institution of Dr. Kasarskis has received research support from Alexion. The institution of Dr. Kasarskis has received research support from Woolsey . Dr. Kasarskis has a non-compensated relationship as a Director of ALSA-supported clinic at the University of Kentucky with ALS Association that is relevant to AAN interests or activities. |
|
|
No disclosure on file |
|
Richard Kryscio
|
No disclosure on file |
|
Eliahu S. Feen, MD
(WellStar Health System / WellStar Neurosciences)
|
No disclosure on file |
|
|
No disclosure on file |
|
Bengt Winblad
|
No disclosure on file |
|
Rup Tandan, MD, FRCP, FAAN
(University of Vermont (UVM)/UVM Medical Center)
|
Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Apellis. Dr. Tandan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Tandan has received research support from Alexion. The institution of Dr. Tandan has received research support from Apellis. The institution of Dr. Tandan has received research support from Cytokinetics. |
|
|
No disclosure on file |